EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Maraviroc Prevents Optic Nerve Injury-Induced Retinal Ganglion Cell Apoptosis by Modulating the CCL5/CCR5/CTSS Axis

Jingqiu Huang, Zhaohui Chang, Lian Liu, Cheng Lai, Xizhi Deng, Bin Jiang, Min Ke

Investigative Ophthalmology & Visual Science · 2025-06-25 · 66 (6) · 77

DOI: 10.1167/iovs.66.6.77 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2025-06-25. Written by Jingqiu Huang and 6 co-authors. Institution: Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Major MEDLINE topics: Maraviroc, Retinal Ganglion Cells, Apoptosis, Optic Nerve Injuries. Cited 6 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

Optic nerve crush (ONC) is an animal model that induces optic nerve injury and retinal ganglion cell (RGC) death, which is partly mediated by activated microglia secreting cytokines. This study explores the role of the CCL5/CCR5 pathway in RGC damage and evaluates maraviroc, a CCR5 inhibitor, as a potential therapeutic agent.

Methods

Bioinformatic analysis of glaucoma datasets (GSE142881 and GSE26299) identified Ccr5 as a key gene linked to acute or chronic RGC injury. The ONC model was used to evaluate the neuroprotective effects of maraviroc or sh-Ccr5 using immunofluorescence, TUNEL staining, optical coherence tomography (OCT), and electrophysiological tests. Co-culture of neuro2a cells with activated BV2 cells examined mechanisms, and intravitreal maraviroc safety and efficacy were evaluated using histological and molecular assays.

Results

CCR5 was significantly associated with RGC injury in both datasets. Inhibition of CCR5 via maraviroc preserved RGC structure, maintained ganglion cell complex (GCC) thickness, and improved retinal function in the ONC model. Mechanistically, CCR5 inhibition prevented Cathepsin S (CTSS) downregulation and neuron apoptosis induced by ONC or activated microglia. Intravitreal maraviroc administration was safe, preserving retinal structure and RGC count in non-injured eyes while reducing RGC damage in ONC-injured eyes.

Conclusions

Microglial activation in glaucoma upregulates CCL5, triggering CCR5-mediated RGC apoptosis via CTSS downregulation. Maraviroc effectively reduces RGC death and optic nerve damage, offering a promising neuroprotective strategy for treatment of optic nerve injury.

Subjects

MeSH terms (MEDLINE)

MaravirocRetinal Ganglion CellsApoptosisOptic Nerve InjuriesReceptors, CCR5Chemokine CCL5CCR5 Receptor AntagonistsAnimalsDisease Models, AnimalMiceTomography, Optical CoherenceIntravitreal InjectionsMaleMice, Inbred C57BLIn Situ Nick-End LabelingNeuroprotective Agents

Substances

MaravirocReceptors, CCR5Chemokine CCL5CCR5 Receptor AntagonistsNeuroprotective Agents

Authors and institutions

  • Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

Cite

APA

Huang, J., Chang, Z., Liu, L., Lai, C., Deng, X., Jiang, B., & Ke, M. (2025). Maraviroc Prevents Optic Nerve Injury-Induced Retinal Ganglion Cell Apoptosis by Modulating the CCL5/CCR5/CTSS Axis. Investigative Ophthalmology & Visual Science, 66(6), 77. https://doi.org/10.1167/iovs.66.6.77

Vancouver

Huang J, Chang Z, Liu L, Lai C, Deng X, Jiang B, et al. Maraviroc Prevents Optic Nerve Injury-Induced Retinal Ganglion Cell Apoptosis by Modulating the CCL5/CCR5/CTSS Axis. Investigative Ophthalmology & Visual Science. 2025;66(6):77. doi:10.1167/iovs.66.6.77

BibTeX
@article{Huang2025,
  author = {Huang, Jingqiu and Chang, Zhaohui and Liu, Lian and Lai, Cheng and Deng, Xizhi and Jiang, Bin and Ke, Min},
  title = {Maraviroc Prevents Optic Nerve Injury-Induced Retinal Ganglion Cell Apoptosis by Modulating the CCL5/CCR5/CTSS Axis},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  volume = {66},
  number = {6},
  pages = {77},
  doi = {10.1167/iovs.66.6.77}
}
Start for free →